吡嗪酰胺
Pyrazine-2-carboxamide;2-Carbamylpyrazine;Aldinamid;Aldinamide;Eprazin;Farmizina;MK 56;NCI-C01785;Pyrazinecarboxamide;Pyrazinamide;Pyrafat;pyrazine-2-carboxylic acid amide;pyrazinecarboxylic acid amide;pyrazinoic acid amide;Tebrazid;Zinamide;Pyrazinoic acid amide;W-100059;Tox21_202059;PYRAZINAMIDE [HSDB];s1762;MLS000069730;Pyrizinamide;2-carbamyl pyrazine;SCHEMBL24102;DB00339;NCGC00090695-05;NCGC00015833-08;Pyrazinamide, Pharmaceutical Secondary Standard; Certified Reference Material;Pirazinamida (INN-Spanish);PYRAZINAMIDE [MART.];Pirazinamida;Pezetamid;Pyrazinamidum;PYRAZINAMIDE (MART.);pyrazinamide tablet;PZA;Pyrazinamide, United States Pharmacopeia (USP) Reference Standard;NCGC00015833-25;alpha-pyrazinamide;HMS1569H09;5-25-04-00178 (Beilstein Handbook Reference);EN300-15621;SR-01000076077-6;FT-0659757;SR-01000076077-1;C01956;HMS1920N08;P0633;2-pyrazine carboxamide;pyrazine carboxylamide;Unipyranamide;Pyrazine carboxamide;Rifafour e-200;WLN: T6N DNJ BVZ;J04AK01;Pyrazinecarboxamide, analytical standard;Q417571;Tisamid;NCGC00261696-01;Z33546644;UNII-2KNI5N06TI;KSC-27-052E;BB 0253141;NSC-14911;SBI-0050984.P004;BPBio1_000515;NCGC00015833-16;NSC-757304;KBio1_000241;SR-01000076077-4;Pirazimida;HY-B0271;AZT + Pyrazinamide combination;Prestwick3_000514;BCP30257;T 165;NSC14911;Pyrazinamide (Pyrazinoic acid amide);KBio3_001792;NCGC00015833-05;NCGC00015833-15;Isopas;NCGC00015833-06;.alpha.-pyrazinamide;GTPL7287;PYRAZINAMIDE [USP MONOGRAPH];PYRAZINAMIDUM [WHO-IP LATIN];NCGC00090695-06;NCGC00015833-04;NCGC00259608-01;Pyrazinecarboxylic acid amide;Pirazinamide;NCGC00015833-03;SY013550;Pirazinamide [DCIT];HMS2092E09;KBio2_001382;D-50;pyrazinecarboxamide;1,2-dihydro-1,2,4-triazol-3-one;Pyrazinamide;AB00052083-16;Pyrazinamide (USP:INN:BAN:JAN);HMS500M03;pyrazine-2-carboximidic acid;2-(AMINOCARBONYL)PYRAZINE;D-50 (VAN);Spectrum4_001186;PYRAZINAMIDE [WHO-DD];LP01011;Pyrazinamdie;SMR000036662;Pyrazinamide, British Pharmacopoeia (BP) Reference Standard;Pyrazinamide-15N,d3;DTXCID801215;PYRAZINAMIDE [EP MONOGRAPH];pyrazine amide;PYRAZINAMIDE [VANDF];Pyrazinamidum [INN-Latin];AKOS000120280;BRN 0112306;CAS-98-96-4;Lopac-P-7136;HMS3259O04;Pirazinamida [INN-Spanish];CAS- 98-96-4;D70481;BSPBio_000467;HMS3371G09;HMS2096H09;SPECTRUM1500518;Rifafour;Pyrazinamide (TN);Pyrazinamide [USP:INN:BAN:JAN];AB00052083_18;MLS002222347;DTXSID9021215;PYRAZINAMIDE (EP MONOGRAPH);Pyrazinamid;NCGC00090695-04;DivK1c_000241;PYRAZINAMIDE [MI];Pyrazinamide (JP17/USP/INN);NCGC00256336-01;HMS2235G17;KBioSS_001382;RIFATER COMPONENT PYRAZINAMIDE;DRG 0124;Pyranzinoic acid amide;CHEMBL614;BDBM228814;NC00534;AB00052083_17;Prestwick_811;NCGC00015833-02;NSC757304;NCGC00015833-11;NCGC00015833-10;Spectrum3_001046;Pyrazinamidum (INN-Latin);PYRAZINAMIDE [ORANGE BOOK];Pyrazide;Pyrazine-2-carboxylic acid amide;NS00010008;InChI=1/C5H5N3O/c6-5(9)4-3-7-1-2-8-4/h1-3H,(H2,6,9;Tox21_110237_1;HMS36...